HC
Therapeutic Areas
Laboratoires Théa Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TLM-003 | Myopia Progression | Phase 2 |
| ILYX-002 | Autoimmune-Associated Dry Eye Disease | Preclinical/Phase 1 |
| Sepofarsen | CEP290-associated Leber Congenital Amaurosis Type 10 (LCA10) | Phase 3 |